Sakar Healthcare Board to Consider Q2 Results on 23rd October 2026
Sakar Healthcare Ltd 路 Intimation 路 23 Oct 2026, 5:30 am
Sakar Healthcare Board to Consider Q2 Results on 23rd October 2026 Sakar Healthcare Limited has scheduled a meeting of its Board of Directors on 23rd Oct'26 to consider and approve the unaudited financial results for the quarter ended 30th Sep'26, alongside other business matters. In accordance with SEBI Insider Trading Regulations and the company's Code of Conduct, the trading window for designated persons remains closed until 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Sakar Healthcare Ltd
- Sakar Healthcare Limited has informed the Exchange about Transcript 路 02 Nov 2026
- Sakar Healthcare Limited has informed the Exchange about Link of Recording 路 27 Oct 2026
- Sakar Healthcare Limited has informed the Exchange about Investor Presentation 路 26 Oct 2026
- Sakar Healthcare Limited has informed the Exchange regarding a press release dated October 26, 2026, titled "Press Release - Consolidated and Standalone Unaudited Financial Results for the quarter and half year ended September 30, 2026". 路 26 Oct 2026
- Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 23 Oct 2026
- Sakar Healthcare Limited has informed the Exchange about Schedule of meet 路 27 Oct 2026
- SAKAR HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 23-Oct-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 23 Oct 2026
- Sakar Healthcare Limited has informed the Exchange about Sakar s global export model expands with oncology products 路 14 Oct 2026
